biotics receiving the greatest attention are cefoperazone (T-1551), cefotaxime (HR756), moxalactam (LY127935 or 6059-S), azlocillin, mezlocillin, and piperacillin (3, 5, 7, 13, 17 ; T. Yoshida, M. Narisada, S. Matsuura, W. Nagata, and S. Kuwahara, Program Abstr. Intersci. Conf. Antimicrob. Agents Chemother. 18th, Atlanta, Ga., abstr. no. 151, 1978) .
In this study, the in vitro antimicrobial activity of 13 /3-lactam antimicrobial drugs against recent clinical isolates of N. gonorrhoeae and H. influenzae was determined.
The antimicrobial agents tested were received from Pfizer Inc., New York, N. Y. (cefoperazone); Hoechst-Roussel Pharmaceuticals, So- influenzae strains were randomly selected from isolates referred to the Antimicrobics Investigation Section, Center for Disease Control, Atlanta, Ga. in 1979. Equal numbers of /3-lactamase-positive (fB-lac+) and /8-lactamase-negative (f8-lac-) bacteria were tested. The minimum inhibitory concentrations (MICs) were determined by methods previously described (1, 2, 4, 13). The disk diffusion tests for H. influenzae and N. gonorrhoeae were performed on Mueller-Hinton agar plus 1% hemoglobin and 1% IsoVitaleX (BBL Microbiology Systems, Cockeysville, Md.) and on GC agar base plus 1% IsoVitaleX, respectively (1, 2, 13 Table  2 and by cumulative percent inhibition in Fig. 1 2, 4, 11, 13, 15 ). Among the cephalosporins that are now being marketed, cefuroxime has been shown to be the most active against ,B-lacand ,B-lac+ strains of gonococci (10, 11, 15) . Piperacillin and mezlocillin have marked activity against both /8-lac-and f3-lac' strains of gonococci. This confirms a previous report from our laboratory on the unique activity of piperacillin on gonococci (13) . (Table  1 ). There were also increases in cephalosporin MICs for the 8)-lac' strains when geometric means were examined; for most of these drugs, the change was minimal, with the largest ratio being 10:1 for moxalactam.
The increases in modal and geometric mean MICs of the penicillins were lowest with piperacillin and mezlocillin. The smallest changes in zone diameters were obtained with cefotaxime, and the largest changes in zone diameters were obtained with azlocillin and mezlocillin. These results may indicate that all of these drugs could be at least slightly susceptible to hydrolysis by this f)-lactamase. Increased resistance to these drugs, however, may be due to a mechanism such as cell wall permeability or to a combination of mechanisms (6, 13) . As both f8-lac' N. gonorrhoeae and H. influenzae produce the TEM type III enzyme, the difference in activity of a fl-lactam drug on these two organisms is due to a mechanism other than the action of the enzyme (13) . This is the case with piperacillin, which is more active on f8-lac' N. gonorrhoeae than on ,8-lac+ H. influenzae.
The general activity of the drugs under investigation on these two genera is impressive and may indicate that they merit evaluation in clinical trials. Cephalosporins have not been used to treat patients with meningitis because therapeutic levels were not readily obtained in the spinal fluid. However, cefotaxime and moxalactam inhibited all strains of H. influenzae (including f8-lac+) at a concentration of 0.06 ,ug/ml, and the highest cefoperazone MIC was 0.5 ,ug/ml. It is possible that these levels can be achieved and that they can be used to treat patients with meningitis. In addition, cephalosporins have not been generally recommended for the treatment of patients with gonorrhea, but the latest Center for Disease Control guidelines include cefoxitin as a suggested alternative, and cefuroxime appears to be promising (8, 11) . As the three new cephalosporins are extremely active against both B-lac-and f,-lac+ gonococci, they deserve expanded clinical trials in the treatment of gonococcal infections.
Piperacillin and mezlocillin are very active against both f8-lac' and f8-lac-gonococci and appear to be resistant (or at least relatively resistant) to TEM ,8-lactamase. They deserve to be considered for clinical trials in the treatment of gonorrhea. The use of these penicillins in the treatment of patients with some H. influenzae infections would, however, have to be approached with more caution as some strains would require at least 128 jig/ml for inhibition, a level which is not likely to be achieved in the spinal fluid or the middle ear.
In conclusion, these /3-lactam antibiotics under investigation are generally more active in vitro on N. gonorrhoeae and H. influenzae than the more generally available /3-lactam drugs used in this study.
